Capital-FORCE ETFMid-Cap GrowthBOUT · NYSE Arca

CapForce IBD Breakout Opportunities ETF (BOUT)

Compare categoryCompare US Mid Cap ETFs Compare with others

Price: $39.04; —12 Nov 2026
Assets: $14.3M; Total net assets
Expense ratio: 0.80%; Category 1.05%
Yield: 0.31%; Trailing distributions

1Y return: 4.1%+0.6%; Category 3.6%
3Y CAGR: 10.3%-7.6%; Category 17.9%
5Y CAGR: 1.3%-0.2%; Category 1.6%

$39.04—12 Nov 2026

Fund

Assets: $14.3M
Expense: 0.80%
Categ. exp: 1.05%
Yield: 0.31%

ReturnFundCateg.

1Y4.1%3.6%

3Y10.3%17.9%

5Y1.3%1.6%

Launch6.2%—

Loading NAV history…

CapForce IBD Breakout Opportunities ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	-7.7%	-12.7%	-16.9%	+7.6%	+4.1%	+10.3%	+1.3%	—	+6.2%
Mid-Cap Growth average	-4.7%	-8.7%	-3.6%	4.5%	3.6%	17.9%	1.6%	12.3%	6.0%
Difference	-3.0%	-4.0%	-13.3%	+3.0%	+0.6%	-7.6%	-0.2%	—	+0.2%

Holdings

The 10 largest positions make up 64.8% of the fund.

Top holdings

Largest holdings by weight
Ticker	Holding	Weight
HNGE	Hinge Health Inc Ordinary Shares - Class A	7.27%
GH	Guardant Health Inc	7.19%
DJCO	Daily Journal Corp	7.03%
TH	Target Hospitality Corp Class A	6.84%
EMBJ	Embraer SA ADR	6.84%
ONC	BeOne Medicines Ltd ADR	6.21%
NTRA	Natera Inc	6.13%
EHC	Encompass Health Corp	6.02%
AUGO	Aura Minerals Inc	5.76%
ETON	Eton Pharmaceuticals Inc	5.46%

Portfolio valuation

Weighted averages of what the fund holds.

P/E: 21.5
P/B: 5.6
P/S: 4.8
P/CF: 17.2

Sector allocation

Share of the equity the fund holds.

Health care39.2%
Technology20.4%
Materials17.4%
Industrials14.7%
Consumer staples4.1%
Energy2.1%
Financial services2.0%

Asset mix

Stocks100.1%
Cash1.1%

ETF details

Issuer: Capital-FORCE ETF
Category: Equity · Mid-Cap Growth
Ticker: BOUT
Exchange: NYSE Arca
Inception: 12 Sept 2018 (8.2 years)
Structure: Exchange Traded Fund
Expense ratio: 0.80% (category 1.05%)
Holdings turnover: 1,668% (category 91%)
Distribution yield: 0.31%
Beta, 3 years: 1.17
Total net assets: $14.3M

Prices and returns as of 12 Nov 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other mid-cap growth ETFs

Other ETFs in the Mid-Cap Growth category.

Compare US Mid Cap ETFs